Literature DB >> 12053166

[Frontal sinus osteomas: neuro-ophthalmological complications].

P Bourgeois1, A Fichten, E Louis, C Vincent, B Pertuzon, R Assaker.   

Abstract

Osteomas are the most frequent benign tumors of the paranasal sinuses. They often grow in the frontal sinus near the nasofrontal duct. They remain frequently asymptomatic and they tend to be an incidental finding on radiographic studies. Rarely, they extend out of the sinus limits. Two cases with neuro-ophthalmological complications are reported and discussed. A 19-year-old female presented with a progressive left visual impairment and orbital bone deformity. A CT-scan revealed a large calcified mass in both frontal sinuses, with left intraorbital and frontobasal extension. A 21-year-old man suffered from acute frontoethmoidal sinusitis. Radiological exams revealed a right frontal sinus osteoma with bilateral nasofrontal ducts obstruction. The frontal sinus cavities were filled with a large mucocele with intracranial extension. Both patients were successfully treated using frontobasal craniotomy with complete osteoma and mucocele removal and cranio facial bone reconstruction. Neuro-ophthalmological or intrasinusal complications of osteomas lead to radical treatment. CT-scan and MRI analysis for surgical purpose and strategy are emphased.

Entities:  

Mesh:

Year:  2002        PMID: 12053166

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  3 in total

1.  Giant frontal osteoma: case report with review of literature.

Authors:  Rajesh Vishwakarma; Shawn T Joseph; Kalpesh B Patel; Arpit Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-20

2.  A giant, complex fronto-ethmoidal ivory osteoma: Surgical technique in a resource-limited practice.

Authors:  Amos Olufemi Adeleye
Journal:  Surg Neurol Int       Date:  2010-12-31

3.  Two huge maxillofacial osteoma cases evaluated by computed tomography.

Authors:  Samira Saati; Nafiseh Nikkerdar; Amin Golshah
Journal:  Iran J Radiol       Date:  2011-12-25       Impact factor: 0.212

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.